209 related articles for article (PubMed ID: 21808024)
1. Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression.
Zhang X; Farrell AS; Daniel CJ; Arnold H; Scanlan C; Laraway BJ; Janghorban M; Lum L; Chen D; Troxell M; Sears R
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2790-5. PubMed ID: 21808024
[TBL] [Abstract][Full Text] [Related]
2. The Axin1 scaffold protein promotes formation of a degradation complex for c-Myc.
Arnold HK; Zhang X; Daniel CJ; Tibbitts D; Escamilla-Powers J; Farrell A; Tokarz S; Morgan C; Sears RC
EMBO J; 2009 Mar; 28(5):500-12. PubMed ID: 19131971
[TBL] [Abstract][Full Text] [Related]
3. Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.
Chimge NO; Ahmed-Alnassar S; Frenkel B
Cell Cycle; 2017 Feb; 16(4):312-318. PubMed ID: 28055379
[TBL] [Abstract][Full Text] [Related]
4. EYA1's Conformation Specificity in Dephosphorylating Phosphothreonine in Myc and Its Activity on Myc Stabilization in Breast Cancer.
Li J; Rodriguez Y; Cheng C; Zeng L; Wong EYM; Xu CY; Zhou MM; Xu PX
Mol Cell Biol; 2017 Jan; 37(1):. PubMed ID: 27795300
[TBL] [Abstract][Full Text] [Related]
5. T-cell Dysfunction upon Expression of MYC with Altered Phosphorylation at Threonine 58 and Serine 62.
Daniel CJ; Pelz C; Wang X; Munks MW; Ko A; Murugan D; Byers SA; Juarez E; Taylor KL; Fan G; Coussens LM; Link JM; Sears RC
Mol Cancer Res; 2022 Jul; 20(7):1151-1165. PubMed ID: 35380701
[TBL] [Abstract][Full Text] [Related]
6. Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.
Janghorban M; Farrell AS; Allen-Petersen BL; Pelz C; Daniel CJ; Oddo J; Langer EM; Christensen DJ; Sears RC
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9157-62. PubMed ID: 24927563
[TBL] [Abstract][Full Text] [Related]
7. RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.
Chimge NO; Little GH; Baniwal SK; Adisetiyo H; Xie Y; Zhang T; O'Laughlin A; Liu ZY; Ulrich P; Martin A; Mhawech-Fauceglia P; Ellis MJ; Tripathy D; Groshen S; Liang C; Li Z; Schones DE; Frenkel B
Nat Commun; 2016 Feb; 7():10751. PubMed ID: 26916619
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland.
Wang X; Cunningham M; Zhang X; Tokarz S; Laraway B; Troxell M; Sears RC
Cancer Res; 2011 Feb; 71(3):925-36. PubMed ID: 21266350
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of the c-Myc Protein via the Modulation of Threonine 58 and Serine 62 Phosphorylation by the Disulfiram/Copper Complex in Oral Cancer Cells.
Chen GS; Chen SY; Liu ST; Hsieh CC; Lee SP; Huang SM
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012403
[TBL] [Abstract][Full Text] [Related]
10. Expression and significance of Wnt signaling components and their target genes in breast carcinoma.
He Y; Liu Z; Qiao C; Xu M; Yu J; Li G
Mol Med Rep; 2014 Jan; 9(1):137-43. PubMed ID: 24190141
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-124-3p.1 promotes cell proliferation through Axin1-dependent Wnt signaling pathway and predicts a poor prognosis of triple-negative breast cancer.
Yang W; Cui G; Ding M; Yang M; Dai D
J Clin Lab Anal; 2020 Jul; 34(7):e23266. PubMed ID: 32125723
[TBL] [Abstract][Full Text] [Related]
12. Myc stabilization in response to estrogen and phospholipase D in MCF-7 breast cancer cells.
Rodrik V; Gomes E; Hui L; Rockwell P; Foster DA
FEBS Lett; 2006 Oct; 580(24):5647-52. PubMed ID: 16996503
[TBL] [Abstract][Full Text] [Related]
13. Peroxynitrite promotes serine-62 phosphorylation-dependent stabilization of the oncoprotein c-Myc.
Raman D; Chong SJF; Iskandar K; Hirpara JL; Pervaiz S
Redox Biol; 2020 Jul; 34():101587. PubMed ID: 32512497
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
[TBL] [Abstract][Full Text] [Related]
15. An investigation on the c-MYC, AXIN1, and COL11A1 gene expression in colorectal cancer.
Moradifard S; Minuchehr Z; Ganji SM
Biotechnol Appl Biochem; 2022 Aug; 69(4):1576-1586. PubMed ID: 34319618
[TBL] [Abstract][Full Text] [Related]
16. Analysis of binding interfaces of the human scaffold protein AXIN1 by peptide microarrays.
Harnoš J; Ryneš J; Víšková P; Foldynová-Trantírková S; Bajard-Ešner L; Trantírek L; Bryja V
J Biol Chem; 2018 Oct; 293(42):16337-16347. PubMed ID: 30166345
[TBL] [Abstract][Full Text] [Related]
17.
Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
[TBL] [Abstract][Full Text] [Related]
18. Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias.
Malempati S; Tibbitts D; Cunningham M; Akkari Y; Olson S; Fan G; Sears RC
Leukemia; 2006 Sep; 20(9):1572-81. PubMed ID: 16855632
[TBL] [Abstract][Full Text] [Related]
19. USP44 suppresses proliferation and enhances apoptosis in colorectal cancer cells by inactivating the Wnt/β-catenin pathway via Axin1 deubiquitination.
Huang T; Zhang Q; Ren W; Yan B; Yi L; Tang T; Lin H; Zhang Y
Cell Biol Int; 2020 Aug; 44(8):1651-1659. PubMed ID: 32285989
[TBL] [Abstract][Full Text] [Related]
20. Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.
Rodrik V; Zheng Y; Harrow F; Chen Y; Foster DA
Mol Cell Biol; 2005 Sep; 25(17):7917-25. PubMed ID: 16107734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
